Hexarelin Peptide
$32.00 – $67.00Price range: $32.00 through $67.00 Select options
Price range: $32.00 through $67.00
Research-grade Hexarelin Acetate (Examorelin), a synthetic hexapeptide (His-D-2-Methyl-Trp-Ala-Trp-D-Phe-Lys-NH2), is designed for controlled investigations of GH secretagogue receptor activity, GHS-R1a/CD36 dual agonism, and GH pulsatility signaling pathways. For Research Use Only. Not for human use.
Description Additional information Peptide Research Storage & Handling
Hexarelin is a synthetic growth hormone secretagogue (GHS) hexapeptide featuring a D-2-methyl-tryptophan substitution that increases metabolic stability and receptor affinity. It binds both GHS-R1a and CD36 receptors, making it a subject of significant scientific interest in in vitro and preclinical research settings. This research-grade lyophilized powder is synthesized under strict quality controls and provided with full analytical documentation. For Research Use Only. Not for human use.
Key Scientific Features
High-purity Hexarelin Acetate (≥98% by HPLC/MS, acetate salt form) Verified hexapeptide sequence with D-2-Me-Trp modification: His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2 Lyophilized formulation for long-term stability Full Certificate of Analysis (COA) with HPLC, MS, and amino acid analysis Manufactured in GMP-aligned, ISO-compliant facilities Studied in the context of GHS-R1a and CD36 receptor signaling research
Research-Referenced Attributes (Based on scientific literature; strictly for in vitro and preclinical research purposes only. Not intended as therapeutic claims.)
Dual GHS-R1a and CD36 receptor binding — subject of ongoing cardiovascular and endocrine signaling research [ahajournals.org] Studied for comparative GH secretagogue receptor activity relative to GHRP-6 and GHRP-2 Subject of preclinical models investigating ischemia, GH axis signaling, and cardiac receptor activation Relevant to in vitro research in endocrine signaling, GH secretagogue receptor pharmacology, and CD36-mediated pathways
Why Researchers Choose Nationwide Peptides Hexarelin Acetate
Exact research sequence with D-2-methyl-Trp modification Transparent analytical data (HPLC ≥98%, MS confirmation) Suitable for endocrinology and cardiovascular receptor signaling laboratory research Competitive research pricing with bulk options
Additional information
Weight .125 lbs Dimensions 9 × 7 × .5 in Size: No selection
2 mg, 5 mg, 10 mg
Peptide Research
Ghigo E et al. (1996) Dose-response in humans [PMID: 7957536, https://pubmed.ncbi.nlm.nih.gov/7957536/]. Locatelli V et al. (2014) Cardiovascular action review [PMC: PMC4178518, https://pmc.ncbi.nlm.nih.gov/articles/PMC4178518/]. Arvat E et al. (1997) No interaction with CRH/AVP [PMID: 9430449, https://pubmed.ncbi.nlm.nih.gov/9430449/]. Ghigo E et al. (1998) Pubertal response [PMID: 9801989, https://pubmed.ncbi.nlm.nih.gov/9801989/]. Deghenghi R et al. (1996) Mechanism in rats [PMID: 8921832, https://pubmed.ncbi.nlm.nih.gov/8921832/]. Benso A et al. (2003) Lipid aberrations in mice [PMC: PMC5659698, https://pmc.ncbi.nlm.nih.gov/articles/PMC5659698/]. Arvat E et al. (1996) Acromegaly/hyperprolactinemia [PMID: 8706295, https://pubmed.ncbi.nlm.nih.gov/8706295/]. Loche S et al. (1995) Short children [PMID: 8548949, https://pubmed.ncbi.nlm.nih.gov/8548949/]. Deghenghi R et al. (1996) Intranasal in children [PMID: 7852535, https://pubmed.ncbi.nlm.nih.gov/7852535/]. Cassoni P et al. (2006) Neuroblastoma SOD1-G93A protection [PMC: PMC9863688, https://pmc.ncbi.nlm.nih.gov/articles/PMC9863688/]. Revolution Health (2025) Hexarelin benefits [https://revolutionhealth.org/blogs/news/peptide-therapy-hexarelin]
Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.